Responsible for the CITIC Industry Fund Pharmaceutical and Equipment Group. He has more than 17 years of working experience in international top investment banks and direct investment institutions. Prior to joining CITIC Industrial Fund, Mr. Wang was a Managing Director of Credit Suisse Investment Banking and a director of the pharmaceutical health industry in the Asia Pacific region. Before that, he held senior positions in the investment banking divisions of UBS and Morgan Stanley in Hong Kong. He has led many Asian medical health and related industry projects, including the initial public offerings of Sinopharm and Greenleaf, the privatization of WuXi PharmaTech and Xiansheng Pharmaceutical, and the acquisition of Acino and Sanofi's acquisition of Meihua Sunstone by Luye Pharmaceuticals. Wait. Prior to returning to China in 2007, Mr. Wang worked in multinational investment banking and multi-strategy hedge funds in New York for seven years.
Dr.Wang has Ph.D. in Medicinal Chemistry from Johns Hopkins University, Master of Business Administration Finance from New York University, Chartered Financial Analyst.